Sd. Bruck, LONG-TERM STABILITY OF INTRAOCULAR LENSES - LITERATURE-REVIEW, ASSESSMENT, AND TESTING PROTOCOL, Journal of long-term effects of medical implants, 3(4), 1993, pp. 333-350
Citations number
55
Categorie Soggetti
Medicine, Research & Experimental",Pathology,"Engineering, Biomedical",Orthopedics
A critical review of the literature confirms the generally excellent,
very long-term clinical stability and performance of polymethylmethacr
ylate (PMMA) in intraocular lenses. In contrast, only short-term, larg
ely nonsystematic data are available on the performance of other, newe
r materials, such as soft silicones based on polydimethylsiloxane and
copolymers of dimethyl- and diphenylsiloxane, hydrogels based on poly(
2-hydroxyethylmethacrylate), and various ''temporary'' and ''permanent
'' hydrophilic coatings. Some conflicting reports have been published
on the long-term stability of isotactic polypropylene loop materials.
However, the medical consensus seems to be that these are essentially
stable to ultraviolet light energy reaching intraocular lenses during
the expected service life in excess of 20 years. Uncertainty still sur
rounds the use of various ultraviolet-absorbing chromophores in the op
tics and/or haptics of intraocular lenses. Published reports indicate
varying transmittance and effectiveness of ultraviolet-absorbing intra
ocular lenses. Furthermore, there is concern about the fate of the ult
raviolet-absorbing chromophores during clinical conditions, especially
with regard to degradation and leaching. Although a number of papers
has been published on the effect of ultraviolet light energy on intrao
cular lenses, the experimental approaches differed substantively, so t
hat intercomparative deductions must be made guardedly. A few papers h
ave been published on the long-term biostability (hydrolytic, oxidativ
e, and enzymatic) of intraocular lens materials. However, much of what
has appeared in the literature is often illustrative of simplistic as
sumptions that largely ignore the environment of the eye. Clearly, the
eventual success of newer materials must be based on performance char
acteristics that exceed those of the time-tested polymethylmethacrylat
e and the refined manufacturing technology designed to transform this
polymer into intraocular lenses. The unquestioned clinical success of
intraocular lenses rests on long historical data with PMMA that are un
available with proposed newer materials. Thus, the entry of such new m
aterials into the commercial market, meriting the acceptance of clinic
ians (and patients), must follow rather than precede thorough in vitro
accelerated testing procedures under conditions that permit intercomp
arative conclusions and recommendations.